Back to Search

IRWIN GELMAN, M.D.

Psychiatry Physician

NPI: 1154447282Individual

Specialties, Licenses & Credentials

Child & Adolescent Psychiatry Physician

Psychiatry & Neurology — Child & Adolescent Psychiatry

Code: 2084P0804X

183990(NY)045463(CT)
Psychiatry PhysicianPrimary

Psychiatry & Neurology — Psychiatry

Code: 2084P0800X

045463(CT)

Research & Publications (20)

v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex.
PMID 17626016·J Biol Chem·2007
7-preclinical
Isolation of novel substrates using a tyrosine kinase overlay/in situ assay.
PMID 12616718·Methods Mol Biol·2003
7-preclinical
The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development .
PMID 12133808·Front Biosci·2002
6-review
Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes.
PMID 11729253·J Am Soc Nephrol·2001
7-preclinical
Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.
PMID 19138410·BMC Cancer·2009
7-preclinical
Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.
PMID 18979199·Dig Dis Sci·2009
8-other
Reovirus infection of cancer cells is not due to activated Ras pathway.
PMID 18949012·Cancer Gene Ther·2009
7-preclinical
Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.
PMID 18593908·Cancer Res·2008
7-preclinical
v-Src-dependent down-regulation of the Ste20-like kinase SLK by casein kinase II.
PMID 16837460·J Biol Chem·2006
7-preclinical
SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition.
PMID 16740695·Cancer Res·2006
7-preclinical
SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis.
PMID 16638134·BMC Cancer·2006
7-preclinical
FAK-dependent regulation of myofibroblast differentiation.
PMID 16585062·FASEB J·2006
8-other
SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.
PMID 16547152·Mol Cancer Res·2006
7-preclinical
Letter of retraction.
PMID 16422027·J Immunol·2005
8-other
Enhanced v-Src-induced oncogenic transformation in the absence of focal adhesion kinase is mediated by phosphatidylinositol 3-kinase.
PMID 15809050·Biochem Biophys Res Commun·2005
7-preclinical
Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202.
PMID 15100361·J Am Soc Nephrol·2004
7-preclinical
Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles.
PMID 15496411·J Biol Chem·2004
7-preclinical
Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol.
PMID 12654740·J Antimicrob Chemother·2003
7-preclinical
Pyk 2 FAKs, any two FAKs.
PMID 12842089·Cell Biol Int·2003
6-review
v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts.
PMID 14500722·J Biol Chem·2003
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
208 VALLEY RD
NEW CANAAN, CT 06840

Location

Practice Location

208 VALLEY RD, NEW CANAAN, CT
(914) 261-2458

Quick Facts

NPI
1154447282
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
3
Locations
1
Publications
20

Are you this provider?

Claim Your Profile